| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 0 | 22.278 | 42.066 | 77.302 | 106.062 | 175.398 | 220.168 |
| Total Income - EUR | - | - | - | 0 | 22.278 | 42.066 | 77.302 | 106.214 | 175.398 | 235.667 |
| Total Expenses - EUR | - | - | - | 0 | 9.835 | 14.756 | 19.641 | 21.478 | 24.760 | 38.260 |
| Gross Profit/Loss - EUR | - | - | - | 0 | 12.443 | 27.310 | 57.661 | 84.736 | 150.638 | 197.407 |
| Net Profit/Loss - EUR | - | - | - | 0 | 11.775 | 26.137 | 56.652 | 83.676 | 148.884 | 191.506 |
| Employees | - | - | - | 0 | 0 | 1 | 2 | 1 | 2 | 2 |
Check the financial reports for the company - Pharmalog Excela S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 880 | 100 | 29.434 | 21.274 | 12.828 | 5.280 | 39.101 |
| Current Assets | - | - | - | 65 | 15.606 | 25.044 | 54.619 | 78.339 | 150.595 | 179.494 |
| Inventories | - | - | - | 22 | 21 | 162 | 158 | 159 | 158 | 0 |
| Receivables | - | - | - | 0 | 15.378 | 24.357 | 35.163 | 70.354 | 121.689 | 169.218 |
| Cash | - | - | - | 43 | 206 | 525 | 19.298 | 7.826 | 28.748 | 10.276 |
| Shareholders Funds | - | - | - | 43 | 11.859 | 37.792 | 56.854 | 83.879 | 149.086 | 191.707 |
| Social Capital | - | - | - | 43 | 84 | 103 | 202 | 203 | 202 | 201 |
| Debts | - | - | - | 901 | 3.847 | 16.686 | 19.038 | 8.392 | 8.376 | 27.984 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4618 - 4618" | |||||||||
| CAEN Financial Year |
4619
|
|||||||||
Comments - Pharmalog Excela S.r.l.